These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31474978)

  • 21. Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.
    Li Y; Yang Y; Chen D; Wang Y; Zhang X; Li W; Chen S; Wong SM; Shen M; Akerley BJ; Shen H
    mBio; 2023 Aug; 14(4):e0051923. PubMed ID: 37222516
    [No Abstract]   [Full Text] [Related]  

  • 22. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
    Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J
    J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mathematical modeling of postcoinfection with influenza A virus and
    Cheng YH; You SH; Lin YJ; Chen SC; Chen WY; Chou WC; Hsieh NH; Liao CM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1973-1988. PubMed ID: 28740377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-1 Signaling Prevents Alveolar Macrophage Depletion during Influenza and
    Bansal S; Yajjala VK; Bauer C; Sun K
    J Immunol; 2018 Feb; 200(4):1425-1433. PubMed ID: 29311363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza a virus and
    Xiang L; Zhou TJ; Zhou LL; Luo J; Qin Z; You JZ; Jian J; Zhao ZY; Zhou YS; Ye YC; Wang HR; Wang BN; Li MY
    J Biol Regul Homeost Agents; 2019; 33(5):1437-1449. PubMed ID: 31637902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses.
    Damjanovic D; Lai R; Jeyanathan M; Hogaboam CM; Xing Z
    Am J Pathol; 2013 Sep; 183(3):868-80. PubMed ID: 23831294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
    Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B
    Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice.
    Lee B; Robinson KM; McHugh KJ; Scheller EV; Mandalapu S; Chen C; Di YP; Clay ME; Enelow RI; Dubin PJ; Alcorn JF
    Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(2):L158-67. PubMed ID: 26001778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice.
    Nakamura S; Davis KM; Weiser JN
    J Clin Invest; 2011 Sep; 121(9):3657-65. PubMed ID: 21841308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza "Trains" the Host for Enhanced Susceptibility to Secondary Bacterial Infection.
    Shirey KA; Perkins DJ; Lai W; Zhang W; Fernando LR; Gusovsky F; Blanco JCG; Vogel SN
    mBio; 2019 May; 10(3):. PubMed ID: 31064834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-Edged Role of Interleukin 17A in Streptococcus pneumoniae Pathogenesis During Influenza Virus Coinfection.
    Ambigapathy G; Schmit T; Mathur RK; Nookala S; Bahri S; Pirofski LA; Khan MN
    J Infect Dis; 2019 Jul; 220(5):902-912. PubMed ID: 31185076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial factors required for Streptococcus pneumoniae coinfection with influenza A virus.
    Chen YY; Huang CT; Li SW; Pan YJ; Lin TL; Huang YY; Li TH; Yang YC; Gong YN; Hsieh YC
    J Biomed Sci; 2021 Aug; 28(1):60. PubMed ID: 34452635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.
    Ivanov S; Renneson J; Fontaine J; Barthelemy A; Paget C; Fernandez EM; Blanc F; De Trez C; Van Maele L; Dumoutier L; Huerre MR; Eberl G; Si-Tahar M; Gosset P; Renauld JC; Sirard JC; Faveeuw C; Trottein F
    J Virol; 2013 Jun; 87(12):6911-24. PubMed ID: 23596287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-10 Counteracts IFN-γ to Alleviate Acute Lung Injury in a Viral-Bacterial Superinfection Model.
    McKelvey M; Uddin MB; Palani S; Shao S; Sun K
    Am J Respir Cell Mol Biol; 2024 Jul; 71(1):110-120. PubMed ID: 38574279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.
    Price GE; Gaszewska-Mastarlarz A; Moskophidis D
    J Virol; 2000 May; 74(9):3996-4003. PubMed ID: 10756011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of coinfection with influenza virus and bacteria on host damage.
    Castro AM; Cabello-Gutiérrez C; Pulido-Camarillo E; García-García AE; Pérez-Torres A
    Gac Med Mex; 2020; 156(4):273-278. PubMed ID: 32831336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.
    Kash JC; Walters KA; Davis AS; Sandouk A; Schwartzman LM; Jagger BW; Chertow DS; Li Q; Kuestner RE; Ozinsky A; Taubenberger JK
    mBio; 2011; 2(5):. PubMed ID: 21933918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza Infection Induces Alveolar Macrophage Dysfunction and Thereby Enables Noninvasive
    Verma AK; Bansal S; Bauer C; Muralidharan A; Sun K
    J Immunol; 2020 Sep; 205(6):1601-1607. PubMed ID: 32796026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
    Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
    Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GP96 Drives Exacerbation of Secondary Bacterial Pneumonia following Influenza A Virus Infection.
    Sumitomo T; Nakata M; Nagase S; Takahara Y; Honda-Ogawa M; Mori Y; Akamatsu Y; Yamaguchi M; Okamoto S; Kawabata S
    mBio; 2021 Jun; 12(3):e0326920. PubMed ID: 34061598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.